Case I This 42 year old army officer presented with weakness of the left foot. For 2 years he had noted cramp in calf, shoulders, and ab,dominal muscles on exercise with a tendency to limp slightly when fatigued. For 6 months he had tended to catch the left foot when walking on rough ground and had noticed slight difficulty climbing stairs and rising from a low chair. In addition he had noted muscular twitching in abdominal, neck, left shoulder and facial muscles.
Examination revealed mild asymmetrical weakness particularly involving right deltoid, both triceps and thenar muscles, trunk and distal leg muscles. The left leg was more severely affected than the right, with slight distal atrophy. The tendon reflexes were all increased especially in the left leg. There was spasticity in both legs and both plantar responses were extensor. Fasciculations were observed in all four limbs and in the tongue. Sensory examination was normal. EMG dorsiflexion of the right foot developed, followed lby weak-variations in the disease indicated the interaction of ness of right knee extension. After a few months this im-factors responsible for relative resistance and susproved and he remained well and able to take part in all ceptibility. They described a patient in whom the disactivities, including sport. However, a further 2 years later, ease had remitted, other diagnoses having been he noted frequent cramp in the right leg, right hand and excluded by clinical investigation. This appears to be abdominal muscles with slowly progressive weakness of the the only report of remission and recovery from motor right leg and hand and slurring of speech. These symptoms neuron disease.' The three patients described here worsened after exertion.
Examination revealed weakness and atrophy of the right illustrate several important aspects of the disease that wrist extensors, triceps and small hand muscles, with some have been neglected in recent reviews. involvement of small hand muscles on the left, and of the First, the initial event in the disease is unknown. 18 and the ocular motor nuclei are also relatively resistant. 5 10 Thirdly, the kinetics of cell loss in the disease are unknown. Patterns of clinical deterioration vary from rapid to slow, and from inexorable to episodic and rapid, as in Cases I and 2. The clinical features of the disease are the result of the inter-relation of denervation from loss of functional motor neurons, reinnervation by collateral sprouting from the motor unit territories of neighbouring motor neurons, and supranuclear effects from damage to the upper motor neuron pathway. Hansen and Ballantyne'9 suggested that collateral sprouting remained effective only as long as the territories of motor units remained in contact and calculated that reinnervation was maximal when 50% of anterior horn cells remained. They suggested that reinnervation ceased when less than 5-10% of cells remained. Postmortem studies suggest that rather more than this number of cells may remain in most cases.'2 13 Nonetheless, the clinical evidence suggests a wide range of susceptibility to motor neuron loss, not only from case to case but at different levels of the cord.13
Furthermore, loss of cells is not related to individual muscles but tends to involve part of a limb, usually affecting the territories of several cord segments.13
Since muscle spindles show loss of both gamma and beta motor innervation in histological studies25 it is apparent that both the small gamma and large alpha motor neurons are involved in the disease.
Fourthly, EMG data on the distribution of reinnervation suggests that the disease is widespread at the time of diagnosis, implying that it has been active and disseminated through the motor system for some time prior to presentation with weakness and atrophy.7 14 15 The characteristic widespread distribution of fasciculation often noted at the time of presentationS 610 as in Cases I and 2, also suggests that there is a long phase of pre-clinical involvement of motor neurons prior to the development of weakness. This early phase of relative resistance is exemplified in Case 1, in whom fatiguability, leading to inability to complete a physical task that he had formerly found easy, was a feature for 6 years prior to the development of weakness and atrophy. neurons is yet apparent.5 10 
Conclusions
These features are important in understanding motor neuron disease. They are consistent with a disease process that presents with relatively focal weakness, atrophy and spasticity after a long preclinical period during which the disease has become disseminated in the motor system. During the course of the disease periods of relative susceptibility or resistance can sometimes be recognised. Currently, there is no clue as to the mode of acquisition or onset of the disease.26 in motor neuron disease. 
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